相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MonitoringCAR-Tcell kinetics in clinical trials by multiparameteric flow cytometry: Benefits and challenges
Ghanashyam Sarikonda et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2021)
Acute myeloid leukemia measurable residual disease detection by flow cytometry in peripheral blood vs bone marrow
Colin D. Godwin et al.
BLOOD (2021)
Guidelines for clinical trials using artificial intelligence - SPIRIT-AI and CONSORT-AI†
Clare McGenity et al.
JOURNAL OF PATHOLOGY (2021)
Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics
Anna S. Nam et al.
NATURE REVIEWS GENETICS (2021)
Gut microbiome stability and dynamics in healthy donors and patients with non-gastrointestinal cancers
Allyson L. Byrd et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Reproducibility of Flow Cytometry Through Standardization: Opportunities and Challenges
Tomas Kalina
CYTOMETRY PART A (2020)
Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy
Claudia X. Dominguez et al.
CANCER DISCOVERY (2020)
The Diagnostic, Prognostic, and Therapeutic Potential of Adaptive Immune Receptor Repertoire Profiling in Cancer
Lindsay G. Cowell
CANCER RESEARCH (2020)
Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC
Matthew D. Hellmann et al.
CLINICAL CANCER RESEARCH (2020)
Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy
Xiaoming Zhong et al.
MOLECULAR CANCER (2020)
Peripheral T cell expansion predicts tumour infiltration and clinical response
Thomas D. Wu et al.
NATURE (2020)
Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma
Benjamin P. Fairfax et al.
NATURE MEDICINE (2020)
Spatially Resolved Transcriptomes-Next Generation Tools for Tissue Exploration
Michaela Asp et al.
BIOESSAYS (2020)
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
Elaine Kilgour et al.
CANCER CELL (2020)
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma (vol 176, 775.e1, 2019)
Hanjie Li et al.
CELL (2020)
Deep Learning-Based Concurrent Brain Registration and Tumor Segmentation
Theo Estienne et al.
FRONTIERS IN COMPUTATIONAL NEUROSCIENCE (2020)
Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4+ T cells to cytokines
Eddie Cano-Gamez et al.
NATURE COMMUNICATIONS (2020)
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma
Nayoung Kim et al.
NATURE COMMUNICATIONS (2020)
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial
Robert Jotte et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors
Lara Gibellini et al.
FRONTIERS IN IMMUNOLOGY (2020)
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors
Michal Slyper et al.
NATURE MEDICINE (2020)
Changing Technologies of RNA Sequencing and Their Applications in Clinical Oncology
Ye Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma
Khalid AbdulJabbar et al.
NATURE MEDICINE (2020)
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
M. C. Liu et al.
ANNALS OF ONCOLOGY (2020)
The FDA approval of pembrolizumab for patients with TMB >10 mut/Mb: was it a wise decision? No
V. Prasad et al.
ANNALS OF ONCOLOGY (2020)
Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence
Satoshi Murahashi et al.
BRITISH JOURNAL OF CANCER (2020)
Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma
Andrew L. Ji et al.
CELL (2020)
Radiomics in medical imaging-how-to guide and critical reflection
Janita E. van Timmeren et al.
INSIGHTS INTO IMAGING (2020)
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition
Barzin Y. Nabet et al.
CELL (2020)
Single-cell transcriptomics in cancer: computational challenges and opportunities
Jean Fan et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial
Thomas Powles et al.
LANCET ONCOLOGY (2020)
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
Ryan Woodhouse et al.
PLOS ONE (2020)
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study
Andjelija Zivanovic Bujak et al.
PLOS MEDICINE (2020)
Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia A Systematic Review and Meta-analysis
Nicholas J. Short et al.
JAMA ONCOLOGY (2020)
Extracellular Vesicles as Biomarkers in Cancer Immunotherapy
Matthen Mathew et al.
CANCERS (2020)
Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I-conceptual challenges
Sergio Rutella et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Circulating tumor DNA and liquid biopsy in oncology
David W. Cescon et al.
NATURE CANCER (2020)
Clonal haematopoiesis: a source of biological noise in cell-free DNA analyses
C. Abbosh et al.
ANNALS OF ONCOLOGY (2019)
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
S. Trebeschi et al.
ANNALS OF ONCOLOGY (2019)
Modulating the microbiome to improve therapeutic response in cancer
Jennifer L. McQuade et al.
LANCET ONCOLOGY (2019)
Novel clinical and radiomic predictors of rapid disease progression phenotypes among lung cancer patients treated with immunotherapy: An early report
Ilke Tunali et al.
LUNG CANCER (2019)
Impact of early inflammatory cytokine elevation after commencement of PD-1 inhibitors to predict efficacy in patients with non-small cell lung cancer
Yuichi Ozawa et al.
MEDICAL ONCOLOGY (2019)
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Takeshi Tanoue et al.
NATURE (2019)
Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis
Gabriele De Rubis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
High sensitivity detection of extracellular vesicles immunecaptured from urine by conventional flow cytometry
Carmen Campos-Silva et al.
SCIENTIFIC REPORTS (2019)
Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages
C. A. Gomez-Roca et al.
ANNALS OF ONCOLOGY (2019)
A multiplex immunofluorescence assay to assess immune checkpoint inhibitor-targeted CD8 activation and tumor colocalization in FFPE tissues.
Tony Navas et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Trends in clinical success rates and therapeutic focus
Helen Dowden et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq
Qianqian Song et al.
CANCER MEDICINE (2019)
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant
Robert R. Redfield et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?
A. Elkrief et al.
ANNALS OF ONCOLOGY (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
Single-Cell RNA Sequencing in Cancer: Lessons Learned and Emerging Challenges
Mario L. Suva et al.
MOLECULAR CELL (2019)
Clonal replacement of tumor-specific T cells following PD-1 blockade
Kathryn E. Yost et al.
NATURE MEDICINE (2019)
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
Gabriele Campanella et al.
NATURE MEDICINE (2019)
RNA sequencing: the teenage years
Rory Stark et al.
NATURE REVIEWS GENETICS (2019)
Tumor mutational burden quantification from targeted gene panels: major advancements and challenges
Laura Fancello et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
Melanie Janning et al.
CANCERS (2019)
Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment
Simon Heeke et al.
CELLS (2019)
The Missing Pieces of Artificial Intelligence in Medicine
Coryandar Gilvary et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood
Songming Peng et al.
CELL REPORTS (2019)
Late-differentiated effector neoantigen-specific CD8+T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment
Michael Fehlings et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
The Role Of Circulating Tumor DNA In Therapeutic Resistance
Chenxin Xu et al.
ONCOTARGETS AND THERAPY (2019)
Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients
Brandilyn A. Peters et al.
GENOME MEDICINE (2019)
Tumor Budding and Cell Nest Size Are Highly Prognostic in Laryngeal and Hypopharyngeal Squamous Cell Carcinoma Further Evidence for a Unified Histopathologic Grading System for Squamous Cell Carcinomas of the Upper Aerodigestive Tract
Melanie Boxberg et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Biological background of the genomic variations of cf-DNA in healthy individuals
J. Liu et al.
ANNALS OF ONCOLOGY (2019)
The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
Mifanwy Reece et al.
FRONTIERS IN GENETICS (2019)
New tools for pathology: a user's review of a highly multiplexed method for in situ analysis of protein and RNA expression in tissue
Jeremie Decalf et al.
JOURNAL OF PATHOLOGY (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA
Susana Junqueira-Neto et al.
ACTA CYTOLOGICA (2019)
Tissue Site and the Cancer Immunity Cycle
Brendan L. Horton et al.
TRENDS IN CANCER (2019)
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel et al.
NATURE REVIEWS CANCER (2019)
Deep Learning for Whole Slide Image Analysis: An Overview
Neofytos Dimitriou et al.
FRONTIERS IN MEDICINE (2019)
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam et al.
JAMA NETWORK OPEN (2019)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Mass cytometry: a powerful tool for dissecting the immune landscape
Yannick Simoni et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
Thomas Powles et al.
LANCET (2018)
PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab
Nicolas Guibert et al.
LUNG CANCER (2018)
Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR
David Zemmour et al.
NATURE IMMUNOLOGY (2018)
Oncologists tap the microbiome in bid to improve immunotherapy outcomes
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
Tissue-Specific Immunoregulation: A Call for Better Understanding of the Immunostat in the Context of Cancer
William Pao et al.
CANCER DISCOVERY (2018)
Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer
Chad Tang et al.
SCIENTIFIC REPORTS (2018)
Single Cell T Cell Receptor Sequencing: Techniques and Future Challenges
Marco De Simone et al.
FRONTIERS IN IMMUNOLOGY (2018)
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
Clare Fiala et al.
BMC MEDICINE (2018)
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
Leeat Keren et al.
CELL (2018)
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
Roger Sun et al.
LANCET ONCOLOGY (2018)
Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning
Nicolas Coudray et al.
NATURE MEDICINE (2018)
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
Frank Stephen Hodi et al.
LANCET ONCOLOGY (2018)
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang et al.
NATURE MEDICINE (2018)
Comprehensive analysis of the clinical immuno-oncology landscape
J. Tang et al.
ANNALS OF ONCOLOGY (2018)
Systematic Review and Meta-Analysis of Intensive Multidisciplinary Intervention for Pediatric Feeding Disorders: How Standard Is the Standard of Care?
William G. Sharp et al.
JOURNAL OF PEDIATRICS (2017)
Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab
Yana G. Najjar et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2017)
Fully automated 5-plex fluorescent immunohistochemistry with tyramide signal amplification and same species antibodies
Wenjun Zhang et al.
LABORATORY INVESTIGATION (2017)
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis
Alexandra Snyder et al.
PLOS MEDICINE (2017)
Optimized Method for Robust Transcriptome Profiling of Minute Tissues Using Laser Capture Microdissection and Low-Input RNA-Seq
Shannon Farris et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
Arthur E. Frankel et al.
NEOPLASIA (2017)
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
Sacha Gnjatic et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Desmoplastic Pattern at the Tumor Front Defines Poor-prognosis Subtypes of Colorectal Cancer
Hideki Ueno et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Extracellular Vesicle Flow Cytometry Analysis and Standardization
Joshua A. Welsh et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients
M. F. Sanmamed et al.
ANNALS OF ONCOLOGY (2017)
Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma
A. Strati et al.
ANNALS OF ONCOLOGY (2017)
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
E. J. Limkin et al.
ANNALS OF ONCOLOGY (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development
Meina Liang et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2016)
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
Priti S. Hegde et al.
CLINICAL CANCER RESEARCH (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis
Krista Dubin et al.
NATURE COMMUNICATIONS (2016)
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
Jeffrey J. Wallin et al.
NATURE COMMUNICATIONS (2016)
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
Chiara Nicolazzo et al.
SCIENTIFIC REPORTS (2016)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Single-cell technologies for monitoring immune systems
Pratip K. Chattopadhyay et al.
NATURE IMMUNOLOGY (2014)
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
Hugo J. W. L. Aerts et al.
NATURE COMMUNICATIONS (2014)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization
Evan W. Newell et al.
NATURE BIOTECHNOLOGY (2013)
Surface markers of lymphocyte activation and markers of cell proliferation
Maria Shipkova et al.
CLINICA CHIMICA ACTA (2012)
Radiomics: Extracting more information from medical images using advanced feature analysis
Philippe Lambin et al.
EUROPEAN JOURNAL OF CANCER (2012)
Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis
Benjamin Weide et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics
Volker Wacheck et al.
Cancer Management and Research (2011)
Monitoring cytokine profiles during immunotherapy
Janet C. Siebert et al.
IMMUNOTHERAPY (2010)
Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays
Wilco de Jager et al.
BMC IMMUNOLOGY (2009)
Tricks with tetramers: how to get the most from multimeric peptide-MHC
Linda Wooldridge et al.
IMMUNOLOGY (2009)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Johan Skog et al.
NATURE CELL BIOLOGY (2008)
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
Ganesh Suntharalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
分享论文
